Eli Lilly & Company Chairman and CEO Dave Ricks sheds light on growth and success, the increase in weight loss drug ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

New research has shown that diet could influence the risk of both depression and Alzheimer's disease (AD). Evidence suggests that depressive symptoms are both a risk factor for AD and a reaction to ...

Prehospital hypoxia, hypotension, and hypocarbia each were associated with poor outcomes after traumatic brain injury, ...

Many people use the terms Alzheimer’s disease and dementia as if they mean the same thing, but they actually refer to ...

Researchers explore the impact of exercise on the short-term regulation of insulin pathways in brain circuits.

Advocates for people diagnosed with Alzheimer’s disease and dementia say the AHCCCS screening process is causing long delays in getting patients the care they need.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults.

Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

Israel and Hamas agreed on the first draft of a ceasefire deal on Wednesday (January 15, 2025), signalling the biggest step yet toward an end to the conflict. Among other things, the 60-day ...